# Filana Therapeutics (FLNA) — Earnings

FLNA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/flna/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.92 |
| EPS estimate | $0.00 |
| EPS surprise | +0.00% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1069530/000143774925026686/sava20250630_10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | $0.00 | −$0.92 | 0.00% | — | — |
| Q1 2025 | May 8, 2025 | $0.00 | −$0.48 | 0.00% | — | — |
| Q4 2024 | Mar 3, 2025 | −$0.58 | −$0.57 | 2.28% | — | — |
| Q3 2024 | Nov 7, 2024 | −$0.73 | −$0.58 | 20.55% | — | — |
| Q2 2024 | Aug 8, 2024 | −$0.41 | $0.13 | 131.96% | — | — |
| Q1 2024 | May 10, 2024 | −$0.46 | −$0.43 | 6.52% | — | — |
| Q4 2023 | Feb 28, 2024 | −$0.52 | −$0.50 | 3.85% | — | — |
| Q3 2023 | Nov 7, 2023 | −$0.78 | −$0.61 | 21.29% | — | — |
| Q2 2023 | Aug 3, 2023 | −$0.59 | −$0.63 | -6.78% | — | — |
| Q1 2023 | May 1, 2023 | −$0.56 | −$0.58 | -4.50% | — | — |
| Q4 2022 | Feb 28, 2023 | −$0.56 | −$0.47 | 16.07% | — | — |
| Q3 2022 | Nov 7, 2022 | −$0.48 | −$0.51 | -6.81% | — | — |
| Q2 2022 | Aug 3, 2022 | −$0.43 | −$0.48 | -10.98% | — | — |
| Q1 2022 | May 5, 2022 | −$0.42 | −$0.44 | -6.02% | — | — |
| Q4 2021 | Feb 28, 2022 | −$0.34 | −$0.35 | -4.48% | — | — |
| Q3 2021 | Nov 10, 2021 | −$0.15 | −$0.24 | -60.00% | — | — |
| Q2 2021 | Aug 3, 2021 | −$0.13 | −$0.13 | -1.56% | — | — |
| Q1 2021 | Apr 21, 2021 | −$0.09 | −$0.09 | -5.88% | — | — |
| Q4 2020 | Mar 23, 2021 | −$0.05 | −$0.09 | -89.47% | — | — |
| Q3 2020 | Nov 9, 2020 | −$0.07 | −$0.06 | 10.04% | — | — |

## Frequently Asked Questions

### When did Filana Therapeutics (FLNA) last report earnings?

Filana Therapeutics last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did FLNA beat earnings estimates?

Filana Therapeutics reported EPS of −$0.92 for Q2 2025, in line with the $0.00 consensus estimate.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).